despit
widespread
vaccin
program
pertussi
continu
common
worldwid
infect
pediatr
adult
popul
past
decad
resurg
diseas
unit
state
european
countri
peak
everi
year
last
peak
report
europ
contrast
report
countri
itali
introduct
acellular
vaccin
incid
continu
decreas
pertussi
reemerg
yet
therefor
epidem
cycl
clearli
less
identifi
due
low
incid
countri
vaccin
schedul
provid
pertussi
vaccin
dose
month
booster
recommend
preschool
period
adolesc
vaccin
coverag
analyz
period
around
sinc
countri
high
immun
coverag
long
period
time
experienc
resurg
pertussi
hypothes
epidemiolog
diseas
itali
may
affect
lack
recognit
clinician
consequ
limit
use
laboratori
confirm
clinic
practic
diagnosi
pertussi
gener
reach
without
microbiolog
confirm
lead
possibl
lack
clinic
awar
start
earli
treatment
prevent
complic
infant
known
acquir
pertussi
adolesc
adult
contact
return
suscept
diseas
wane
immun
well
unvaccin
children
clinic
manifest
may
differ
depend
age
sever
symptom
common
young
unvaccin
infant
pertussi
continu
major
caus
vaccineprevent
death
age
group
howev
case
atyp
clinic
present
occur
may
often
unrecogn
especi
winter
season
respiratori
virus
circul
minimum
incid
pertussi
usual
observ
annual
season
italian
pertussi
incid
peak
march
august
minimum
incid
observ
septemb
februari
therefor
systemat
studi
seri
infant
month
age
hospit
respiratori
symptom
detect
frequent
physician
suspect
pertussi
clinic
basi
actual
frequenc
laboratori
confirm
case
compar
patient
pertussi
infect
patient
respiratori
infect
identifi
clinic
laboratori
predictor
pertussi
describ
characterist
patient
symptom
clinic
find
patient
divid
three
group
patient
bp
posit
aspir
bp
patient
rv
posit
aspir
rv
patient
bp
rv
neg
aspir
bprv
comparison
across
group
perform
anova
continu
measur
chisquar
discret
variabl
assess
symptom
clinic
find
predict
pertussi
appli
logist
regress
model
depend
variabl
dichotom
pertussi
yesno
also
calcul
specif
sensit
clinic
suspicion
pertussi
use
gold
standard
result
rt
pcr
pertussi
nasopharyng
aspir
studi
period
enrol
patient
admiss
diagnosi
patient
report
tabl
patient
test
posit
rtpcr
bp
patient
result
neg
bp
posit
rv
infect
rsv
diagnos
rhinoviru
parainfluenza
viru
adenoviru
metapneumoviru
influenza
viru
coronaviru
rhinoviru
adenoviru
rhinoviru
coronaviru
rsv
adenoviru
parainfluenza
viru
metapmeumoviru
rsv
coronaviru
etiolog
agent
identifi
nasopharyng
aspir
patient
patient
discharg
follow
diagnos
apnea
code
bronchiol
laryngitislaryngomalacia
unexplain
fever
infant
sepsi
pneumonia
intraventricular
septal
defect
enceph
admiss
pertussi
clinic
suspect
patient
basi
definit
sixteen
posit
rtpcr
bp
patient
result
neg
bp
discharg
diagnosi
bronchiol
case
rsv
rhinoviru
parainfluenza
viru
apnea
case
neg
nasopharyng
aspir
hand
among
remain
patient
differ
diagnosi
admiss
rtpcr
posit
bp
thu
sensit
clinic
diagnosi
admiss
specif
clinic
laboratori
characterist
admiss
compar
bp
patient
rv
patient
bprv
patient
tabl
cough
paroxysm
cough
whoop
apnea
fever
rhinorrhea
white
blood
count
lymphocyt
count
length
symptom
admiss
length
hospit
stay
statist
differ
among
three
group
appli
logist
regress
model
explor
predict
clinic
manifest
andor
laboratori
test
pertussi
data
show
paroxysm
cough
absenc
fever
absolut
lymphocyt
count
durat
symptom
admiss
day
significantli
associ
pertussi
compar
diagnos
tabl
notabl
analyz
length
symptom
admiss
patient
bp
found
patient
report
symptom
less
day
patient
report
symptom
day
report
symptom
day
therefor
data
show
apnea
predict
pertussi
frequent
clinic
manifest
among
bp
patient
report
apnea
associ
cough
cyanosi
report
apnea
alon
associ
symptom
complic
oxygen
requir
pneumonia
statist
differ
three
group
death
report
tabl
regard
ongo
antibiot
therapi
patient
bp
vr
bpvr
alreadi
start
antibiot
admiss
particularli
patient
bp
vr
bpvr
alreadi
start
macrolid
therapi
specimen
collect
analyz
season
trend
bp
patient
found
maximum
incid
june
septemb
case
even
winter
peak
februari
fig
regard
coinfect
pertussi
case
posit
rv
result
addit
bp
patient
pcr
posit
rhinoviru
coronaviru
rsv
metapneumoviru
parainfluenza
viru
influenza
coronaviru
rhinoviru
parainfluenza
find
signific
differ
patient
pertussi
monoinfect
patient
pertussi
plu
rv
infect
clinic
suspicion
pertussi
easi
infant
among
patient
bp
pertussi
suspect
patient
admiss
clinic
suspicion
low
sensit
age
group
absenc
systemat
use
laboratori
test
diagnosi
pertussi
infant
respiratori
symptom
mani
infant
bp
infect
may
go
unrecogn
hospit
environ
lack
recognit
infect
may
repres
sever
risk
hospit
outbreak
sinc
pertussi
may
transmit
contact
appropri
antibiot
therapi
appli
matter
fact
observ
hospit
secondari
pertussi
case
studi
period
data
suggest
despit
routin
surveil
show
low
incid
pertussi
itali
bp
infect
still
circul
unvaccin
infant
nearli
patient
younger
month
age
hospit
respiratori
symptom
result
posit
bp
case
seri
accord
previous
report
clinic
manifest
pertussi
overlap
diseas
atyp
nonetheless
data
line
literatur
suggest
featur
alert
clinician
suspect
pertussi
hallmark
clinic
characterist
paroxysm
cough
fever
usual
absent
laboratori
find
show
mark
lymphocytosi
hand
absenc
typic
symptom
exclud
diagnosi
pertussi
furthermor
demonstr
vaccin
children
adolesc
could
silent
mild
pertussi
infect
might
expect
infant
born
mother
receiv
tdap
pregnanc
could
present
modifi
pertussi
seri
infant
born
mother
receiv
booster
pregnanc
note
eight
patient
confirm
bp
infect
admit
diagnosi
apnea
associ
symptom
accord
previous
report
crowcroft
shojaei
ecdc
pertussi
case
definit
apnoeic
episod
infant
includ
clinic
criteria
lack
recognit
bp
infect
infant
import
consequ
surveil
number
infect
hospit
detect
studi
period
seem
consist
nation
surveil
data
suggest
low
circul
pertussi
first
year
life
although
may
experienc
increas
incid
limit
geograph
area
specul
health
facil
systemat
appli
laboratori
confirm
infant
respiratori
symptom
may
miss
case
well
observ
death
case
seri
sinc
case
includ
studi
admit
gener
pediatr
ward
exclud
sever
case
admit
pediatr
intens
care
unit
picu
crowcroft
et
al
previous
studi
describ
infant
month
admit
london
picu
respiratori
failur
apnea
acut
life
threaten
episod
pertussi
report
two
case
death
one
barrier
wide
use
rtpcr
pertussi
may
cost
associ
laboratori
test
beyond
tremend
impact
earli
therapi
pertussi
case
underlin
rtpcr
pertussi
addit
cost
nearli
euro
usd
per
test
use
molecular
assay
becom
standard
care
mani
set
recent
mainli
pcr
advantag
offer
result
within
sever
hour
case
consider
highli
sensit
especi
late
stage
diseas
moreov
affect
use
drug
one
major
use
respect
cultur
method
specimen
could
collect
antibiot
treatment
start
phenotyp
cultur
although
highli
specif
fall
sensit
report
rang
bp
detect
increas
time
releas
test
result
compar
pcr
account
great
limit
pcr
unabl
differenti
asymptomat
carrier
seri
patient
admit
acut
respiratori
symptom
unvaccin
consid
affect
pertussi
properli
treat
pcr
target
use
diagnosi
studi
consequ
distinguish
bp
bordetella
holmesii
bordetella
bronchiseptica
therefor
consid
unlik
data
possibl
overestim
true
data
sequenc
repres
copi
per
cel
bp
consid
advantag
term
high
sensit
detect
notwithstand
microbiologist
infecti
diseas
practition
pediatr
acquaint
low
presenc
target
bordetella
holmesii
copi
per
genom
bordetella
bronchiseptica
well
laboratori
perform
second
pcr
assay
specimen
use
either
bp
bordetella
holmesiispecif
target
howev
target
least
ten
fold
less
sensit
target
sinc
present
fewer
copi
genom
number
potenti
target
sequenc
propos
increas
diagnosi
bp
bordetella
holmesii
recommend
best
pcr
diagnosi
strategi
use
present
time
recommend
refer
final
speci
differenti
pertussi
ill
depend
sever
factor
set
patient
often
relat
immunocompromis
individu
conting
epidemiolog
contest
regard
bordetella
parapertusiss
mani
clinic
laboratori
due
high
preval
pertussi
order
better
exploit
speci
respons
pertussi
diseas
suggest
investig
time
rtpcr
assay
use
bp
specif
bordetella
parapertussi
doubl
check
method
could
repres
appropri
procedur
order
estim
preval
bordetella
pertussisparapertussi
infect
determin
epidemiolog
characterist
infant
although
durat
symptom
bp
patient
longer
diagnos
patient
bp
show
cough
less
day
accord
clinic
case
definit
cdc
ecdc
none
patient
report
similar
observ
report
also
other
case
definit
classif
play
import
role
improv
sensit
pertussi
diagnosi
epidemiolog
survey
criteria
use
pure
clinic
select
pertussi
case
confirm
age
group
may
result
consider
underdiagnosi
pertussi
clinic
suspicion
alway
meet
clinic
criteria
therefor
current
clinic
criteria
pertussi
base
paroxysm
cough
van
den
brink
et
al
previous
demonstr
good
predictor
atyp
pertussi
infect
develop
agerel
case
definit
suggest
gpi
may
import
better
assess
real
burden
pertussi
infant
data
support
previous
report
gonfiantini
et
al
pertussi
season
mani
patient
affect
pertussi
summer
period
nevertheless
case
report
even
winter
respiratori
virus
circul
among
popul
bp
rv
coinfect
document
subject
conflict
result
report
regard
frequenc
concomit
short
durat
surveil
inclus
highli
select
patient
group
base
age
diagnosi
may
contribut
heterogen
find
therefor
previou
studi
taken
account
coinfect
rsv
bp
studi
analyz
coinfect
bp
frequent
rv
clinic
point
view
import
recogn
coinfect
infect
control
clinic
manag
diagnosi
respiratori
viru
infect
exclud
pertussi
viceversa
studi
limit
retrospect
data
collect
medic
record
contain
inaccuraci
regard
clinic
inform
object
paramet
analyz
order
reduc
possibl
bia
second
say
result
may
generaliz
pediatr
set
countri
nonetheless
use
laboratori
test
pertussi
confirm
widespread
itali
despit
eu
recommend
case
definit
report
case
still
diagnos
clinic
base
lastli
nineteen
patient
treat
macrolid
admiss
may
mitig
clinic
manifest
case
sever
strategi
propos
prevent
pertussi
infant
includ
immun
adolesc
adult
tetanu
diphtheria
toxoid
acellular
pertussi
tdap
boost
wane
immun
pertussi
recent
studi
howev
demonstr
tdap
introduct
adolesc
incid
age
group
reduc
averag
incid
pertussi
among
infant
younger
year
significantli
chang
probabl
increas
vaccin
coverag
patient
highest
risk
transmit
diseas
need
indirect
effect
tdap
fulli
realiz
anoth
propos
strategi
matern
immun
third
trimest
pregnanc
octob
advisori
committe
immun
practic
acip
recommend
unvaccin
pregnant
women
receiv
dose
tdap
vaccin
women
tdap
pregnanc
expect
provid
protect
infant
pertussi
old
enough
vaccin
tdap
given
pregnant
women
stimul
develop
matern
antipertussi
antibodi
pass
placenta
like
provid
newborn
protect
pertussi
earli
life
protect
mother
pertussi
around
time
deliveri
make
less
like
becom
infect
transmit
pertussi
infant
england
immun
program
pertussi
pregnant
women
introduc
octob
respons
mark
increas
pertussi
case
particularli
young
infant
program
achiev
vaccin
coverag
vaccin
effect
prevent
infant
diseas
demonstr
vaccin
pregnant
women
consid
like
costeffect
complementari
strategi
prevent
pertussisassoci
infant
mortal
moreov
postpartum
matern
immun
tdap
well
immun
close
household
member
prevent
transmiss
infect
vulner
infant
cocoon
strategi
current
recommend
advisori
committe
immun
practic
center
diseas
control
prevent
sinc
impact
strategi
accur
monitor
without
reliabl
surveil
data
believ
consid
bordetella
pertussi
infect
infant
month
age
hospit
respiratori
symptom
essenti
conclus
clinic
manifest
pertussi
infant
overlap
sever
differ
diseas
sometim
present
may
mimic
viral
respiratori
tract
infect
data
support
routin
use
rtpcr
pertussi
infant
month
age
respiratori
symptom
order
implement
appropri
control
measur
hospit
commun
larg
clinic
suspicion
often
enough
well
recogn
pertussi
infect
bp
bordetella
pertussi
rv
respiratori
virus
rsv
respiratori
syncyti
viru
ic
intern
control
bp
bordetella
pertussi
posit
aspir
rv
respiratori
virus
posit
aspir
bprv
bordetella
pertussi
respiratori
virus
neg
aspir
rtpcr
real
time
polymeras
chain
reaction
picu
pediatr
intens
care
unit
acip
advisori
committe
immun
practic
